| Literature DB >> 28191278 |
Madhuri Tolahunase1, Rajesh Sagar2, Rima Dada1.
Abstract
This study was designed to explore the impact of Yoga and Meditation based lifestyle intervention (YMLI) on cellular aging in apparently healthy individuals. During this 12-week prospective, open-label, single arm exploratory study, 96 apparently healthy individuals were enrolled to receive YMLI. The primary endpoints were assessment of the change in levels of cardinal biomarkers of cellular aging in blood from baseline to week 12, which included DNA damage marker 8-hydroxy-2'-deoxyguanosine (8-OH2dG), oxidative stress markers reactive oxygen species (ROS), and total antioxidant capacity (TAC), and telomere attrition markers telomere length and telomerase activity. The secondary endpoints were assessment of metabotrophic blood biomarkers associated with cellular aging, which included cortisol, β-endorphin, IL-6, BDNF, and sirtuin-1. After 12 weeks of YMLI, there were significant improvements in both the cardinal biomarkers of cellular aging and the metabotrophic biomarkers influencing cellular aging compared to baseline values. The mean levels of 8-OH2dG, ROS, cortisol, and IL-6 were significantly lower and mean levels of TAC, telomerase activity, β-endorphin, BDNF, and sirtuin-1 were significantly increased (all values p < 0.05) post-YMLI. The mean level of telomere length was increased but the finding was not significant (p = 0.069). YMLI significantly reduced the rate of cellular aging in apparently healthy population.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28191278 PMCID: PMC5278216 DOI: 10.1155/2017/7928981
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Details of activities in a day of Yoga and Meditation based Lifestyle Intervention (YMLI) program.
| S. No. | Practice to be done | Duration | ||
|---|---|---|---|---|
| (1) | Session preparation instructions | 5 min | ||
|
| ||||
| (2) | Prayer | 3 min | ||
| Loosening practices (warm-up) | 5 min | |||
|
| ||||
| (3) | Asanas (Postures) | Supine | Shavasana | 2 min |
| Uttanpadasana | 2 min | |||
| Pawanmuktasana | 2 min | |||
| Prone | Makarasana | 2 min | ||
| Bhujangasana | 2 min | |||
| Salabhasana | 2 min | |||
| Sitting | Vakrasana | 2 min | ||
| Ardha-Matsyendrasana | 2 min | |||
| Vajrasana | 2 min | |||
| Standing | Tadasana | 2 min | ||
| Vrikshasana | 2 min | |||
| Ardhachakrasana | 2 min | |||
|
| ||||
| (4) | Relaxation | Shavasana | 5 min | |
|
| ||||
| (5) | Pranayama (Breathing Exercises) | Nadishodhana | 20 min | |
| Bhramri | ||||
| Shitkari | ||||
| Shitali | ||||
| Brahmamudra | ||||
|
| ||||
| (6) | Aumkar recitation | 3 min | ||
|
| ||||
| (7) | Dhyana (Meditation) | 20 min | ||
|
| ||||
| (8) | Shanti mantra | 5 min | ||
|
| ||||
| (9) | Interactive session (first 2 weeks only at Integrated Health Clinic, AIIMS, New Delhi) | 30 min | ||
|
| ||||
| Total | 120 min | |||
Figure 1Flow diagram of study participation.
Sociodemographic characteristics of participants.
| Variable | Values |
|---|---|
| Age (years) |
|
| Sex | |
| Female |
|
| Male |
|
| Socioeconomic status | |
| Kuppuswamy socioeconomic status scale | |
| Education | 4.82 (1.24) |
| Occupation | 5.26 (2.38) |
| Income | 8.60 (2.74) |
| |
|
| BMI (kg/m2) |
|
Data were described as frequency (%) for sex and mean (SD) for others.
Change in outcomes in apparently healthy sedentary subjects participating in a Yoga and Meditation based lifestyle intervention (n = 94).
| Characteristics | Baseline | 12 wks | Change from baseline to 12 wks | Effect size |
|
|---|---|---|---|---|---|
| Primary endpoints: cardinal biomarkers of cellular aging | |||||
|
| |||||
| ROS (RLU/min/104 neutrophils) | 1215.069 ± 88 | 1020.81 ± 79 | 194.3 (164, 224.5) | 0.7 | <0.0001 |
| TAC (mmol Trolox equiv/L) | 5.94 ± 1.52 | 7.4 ± 2.1 | −1.16 (−1.9, −0.41) | 0.4 | <0.001 |
|
| |||||
| 8OH2dG (pg/mL) | 1026.23 ± 630 | 790.98 ± 400 | 235.3 (72.73, 397.8) | 0.22 | <0.01 |
|
| |||||
| Telomerase activity (IU/cell) | 1.89 ± 1.42 | 2.94 ± 2.2 | −1.05 (−1.68, −0.41) | 0.3 | <0.001 |
| Telomere length (IU/cell) | 2.36 ± 1.6 | 2.44 ± 1.4 | −0.08 (−0.61, 0.45) | 0.02 | 0.069 |
| Secondary endpoints: biomarkers associated with cellular aging | |||||
| Cortisol (ng/mL) | 118.83 ± 50.50 | 96.32 ± 38.6 | 22.51 (7.6, 37.42) | 0.3 | <0.01 |
| Interleukin (IL6) (pg/mL) | 3.16 ± 2.42 | 1.94 ± 2.3 | 1.22 (0.47, 1.97) | 0.3 | <0.001 |
| | 6.2 ± 3.5 | 8.2 ± 4.2 | −2 (−3.22, −0.77) | 0.3 | <0.001 |
| BDNF (ng/mL) | 19.7 ± 6.75 | 37.1 ± 5.6 | −17.4 (−19.48, −15.32) | 0.7 | <0.0001 |
| Sirtuin (ng/mL) | 26.69 ± 10.42 | 40.64 ± 11.6 | −13.95 (−23.41, −4.49) | 0.5 | <0.01 |
|
| 26.30 ± 3.40 | 23.64 ± 3.55 | 2.66 (0.56, 3.12) | 0.4 | <0.01 |
Effect size was calculated by dividing change by standard deviation at baseline of the specific outcome and interpreted using Cohen's d (small effect: 0.2 to 0.3, medium effect: 0.5, and large effect: 0.8).